Font Size: a A A
Keyword [Non small cell lung carcinoma]
Result: 101 - 120 | Page: 6 of 7
101. The Systematic Review And Medication Rules Of Traditional Chinese Medicine Combined With EGFR-TKIs In The Treatment Of Non-small-Cell Lung Carcinoma
102. Analysis The Expression And Prognosis Of Tim-3 In Non-small-cell Lung Cancer
103. The PD-L1 Expression Related Clinical Factors Andthe Relationship With The Prognosis In Non-smallcell Carcinoma
104. The Expression Of RACK1,VEGF,SOX2 And P40 In Non-small Cell Lung Carcinoma And Its Significance
105. Studies On The Association Of EZH2 Expression With Its Clinicopathological Features?prognosis And Biological Behaviors In Non-small Cell Lung Carcinoma
106. The Prognostic Value Of 18F-FDG PET/CT In Patients With Stage ? Non-small Cell Lung Carcinoma
107. Preparation Of Gypenoside L And Gypenoside LI And Their Screening And Mechanism Of Action On Different Cancer Cells
108. Research Of Alternative Splicing Induced By Paclitaxel And Function Of Splicing Factor RBM25 In Human Non-Small Cell Lung Cancer
109. Metformin Inhibits IL-6-induced Epithelial-mesenchymal Transition(EMT)and Metastasis In Lung Adenocarcinoma
110. Effects Of CXCR4~+ Non-small Cell Lung Carcinoma Cells On Osteoclastogenesis And The Underlying Mechanism
111. Synthesis And Anti-non-small Cell Lung Carcinoma Activity Of Novel Tetrandrine Derivatives
112. Clinical Significance Of Sparcl1 Expression In Patients With Non-small Cell Lung Cancr And The Biological Function
113. CBL-B Protein Can Treat The Expression Of EGFR In Non-small-cell Lung Carcinoma By Inhibiting Activation Of EGFR
114. Postoperative Recurrence And Metastasis And Survival Analysis Of Stage ? Non-small Cell Lung Carcinoma
115. Expression And Clinical Significance Of Amyloid Precursor Protein In Non-small-cell Lung Carcinoma
116. Study The Mechanism Of Alocasia Rhizome In Treatment Of Non-small Cell Lung Carcinoma(NSCLC)
117. The Efficacy Of First-Generation EGFR-TKIs And Second-Generation EGFR-TKIs In The Treatment Of Advanced Non-Small Cell Lung Cancer:A Meta-Analysis
118. The Study On The Expression,Prognostic Value And Function Of CGAS In Non-small Cell Lung Carcinoma
119. Study On Screening And Activity Evaluating Of BTK Or EGFR Inhibitors
120. Clinical Study Of Radiofrequency Ablation For Subcentimeter GGN Non-small-cell Lung Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to